Table 3.

Adverse events reported within the first week of the study

	AL	AAcf	AAcp	P value
No. of children	81	100	104	–
Total reporting adverse event	19	24	23	0.95
Cough	9	7	7	0.40
Pruritus	0	3	3	0.26
Vomiting	1	2	2	0.90
Abdominal pain	0	3	7	0.02
Weakness	2	5	4	0.66
Insomnia	0	0	3	0.053
Diarrhea	3	3	2	0.78
Herpes labialis	0	2	1	0.43
Excessive salivation	1	4	1	0.27
Rashes	2	1	2	0.71
Puffy face	1	0	1	0.55
Dizziness	0	1	1	0.66
Headache	0	1	0	0.41

AL = artemether-lumefantrine; AAcf = artesunate-amodiaaquine coformulated; AAcp = artesunate-amodiaquine copackaged.